GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Fluicell AB (OSTO:FLUI) » Definitions » EV-to-Revenue

Fluicell AB (OSTO:FLUI) EV-to-Revenue : 15.25 (As of Jun. 21, 2024)


View and export this data going back to 2018. Start your Free Trial

What is Fluicell AB EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Fluicell AB's enterprise value is kr28.40 Mil. Fluicell AB's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 was kr1.86 Mil. Therefore, Fluicell AB's EV-to-Revenue for today is 15.25.

The historical rank and industry rank for Fluicell AB's EV-to-Revenue or its related term are showing as below:

OSTO:FLUI' s EV-to-Revenue Range Over the Past 10 Years
Min: -1.17   Med: 26.28   Max: 145.68
Current: 15.24

During the past 9 years, the highest EV-to-Revenue of Fluicell AB was 145.68. The lowest was -1.17. And the median was 26.28.

OSTO:FLUI's EV-to-Revenue is ranked worse than
63% of 1035 companies
in the Biotechnology industry
Industry Median: 7.54 vs OSTO:FLUI: 15.24

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-06-21), Fluicell AB's stock price is kr0.0898. Fluicell AB's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 was kr0.01. Therefore, Fluicell AB's PS Ratio for today is 6.41.


Fluicell AB EV-to-Revenue Historical Data

The historical data trend for Fluicell AB's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Fluicell AB EV-to-Revenue Chart

Fluicell AB Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-Revenue
Get a 7-Day Free Trial Premium Member Only 24.85 48.72 84.68 12.07 4.33

Fluicell AB Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EV-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 14.21 6.80 4.94 4.33 12.38

Competitive Comparison of Fluicell AB's EV-to-Revenue

For the Biotechnology subindustry, Fluicell AB's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Fluicell AB's EV-to-Revenue Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Fluicell AB's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Fluicell AB's EV-to-Revenue falls into.



Fluicell AB EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Fluicell AB's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=28.404/1.863
=15.25

Fluicell AB's current Enterprise Value is kr28.40 Mil.
Fluicell AB's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr1.86 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Fluicell AB  (OSTO:FLUI) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Fluicell AB's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=0.0898/0.014
=6.41

Fluicell AB's share price for today is kr0.0898.
Fluicell AB's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr0.01.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Fluicell AB EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Fluicell AB's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Fluicell AB (OSTO:FLUI) Business Description

Traded in Other Exchanges
Address
Biotech-Huset, van 7, Arvid Wallgrens Backe 20, Gothenburg, SWE, SE-413 46
Fluicell AB is a provider of high resolution SINGLE-CELL DISCOVERY PLATFORMS for biomedicine, drug development, and bioprinting. The company's products include Biopen, Dynaflow.

Fluicell AB (OSTO:FLUI) Headlines

No Headlines